Loading…
Interstitial photodynamic therapy and glioblastoma: Light fractionation in a preclinical model
Background Glioblastoma is a high‐grade cerebral tumor with local recurrence and poor outcome. Photodynamic therapy (PDT) is a localized treatment based on the light activation of a photosensitizer (PS) in the presence of oxygen, which results in the formation of cytotoxic species. The delivery of f...
Saved in:
Published in: | Lasers in surgery and medicine 2017-07, Vol.49 (5), p.506-515 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Glioblastoma is a high‐grade cerebral tumor with local recurrence and poor outcome. Photodynamic therapy (PDT) is a localized treatment based on the light activation of a photosensitizer (PS) in the presence of oxygen, which results in the formation of cytotoxic species. The delivery of fractionated light may enhance treatment efficacy by reoxygenating tissues.
Objective
To evaluate the efficiency of two light‐fractionation schemes using immunohistological data.
Materials and Methods
Human U87 cells were grafted into the right putamen of 39 nude rats. After PS precursor intake (5‐ALA), an optic fiber was introduced into the tumor. The rats were randomly divided into three groups: without light, with light split into 2 fractions and with light split into 5 fractions. Treatment effects were assessed using brain immunohistology.
Results
Fractionated treatments induced intratumoral necrosis (P |
---|---|
ISSN: | 0196-8092 1096-9101 |
DOI: | 10.1002/lsm.22620 |